Zoetis

$158.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.13 (+2.02%) As of 5:16 PM UTC today

Why Robinhood?

You can buy or sell Zoetis and other stocks, options, and ETFs commission-free!

About ZTS

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ. The listed name for ZTS is ZOETIS INC.

CEO
Kristin C. Peck
Employees
11,300
Headquarters
Parsippany, New Jersey
Founded
1952
Market Cap
76.74B
Price-Earnings Ratio
45.36
Dividend Yield
0.55
Average Volume
2.58M
High Today
$158.72
Low Today
$155.93
Open Price
$156.34
Volume
469.13K
52 Week High
$176.64
52 Week Low
$90.14

ZTS News

BenzingaFeb 28

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among

ZTS Earnings

$0.64
$0.79
$0.95
$1.10
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.87 per share
Actual
$0.91 per share
Replay Earnings Call

You May Also Like

VEON
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure